首页> 外文期刊>Critical Reviews in Biomedical Engineering >Retinal Pigment Epithelium Differentiation of Stem Cells: Current Status and Challenges
【24h】

Retinal Pigment Epithelium Differentiation of Stem Cells: Current Status and Challenges

机译:干细胞视网膜色素上皮分化的现状和挑战

获取原文
获取原文并翻译 | 示例
           

摘要

Degeneration and loss of retinal pigment epithelium (RPE) is the cause of a number of degenerative retinal diseases, including age-related macular degeneration (AMD), retinitis pigmentosa, and diabetic retinopathy, leading to blindness that affects three million Americans as of now. Transplantation of RPE aims to restore retinal structure and the interaction between the RPE and photoreceptors, which is fundamental to sight. Although a significant amount of progress has been made in the past 20 years in autologous RPE transplantation, sources for RPE cells are limited. Recent advances in stem cell culture and differentiation techniques have allowed the generation of RPE cells from pluripotent stem cells. In this review, we discuss strategies for generating functional RPE cells from human embryonic stem cells and induced pluripotent stem cells, and summarize transplantation studies of these derived RPEs. We conclude with challenges in cell-replacement therapies using human embryonic and induced pluripotent stem cell-derived RPEs.
机译:视网膜色素上皮(RPE)的变性和丧失是许多变性性视网膜疾病的原因,包括与年龄有关的黄斑变性(AMD),色素性视网膜炎和糖尿病性视网膜病变,导致失明,目前影响300万美国人。 RPE移植旨在恢复视网膜结构以及RPE与感光器之间的相互作用,这对视觉来说是至关重要的。尽管在过去的20年中自体RPE移植取得了很大的进步,但RPE细胞的来源是有限的。干细胞培养和分化技术的最新进展已允许从多能干细胞生成RPE细胞。在这篇综述中,我们讨论了从人类胚胎干细胞和诱导性多能干细胞生成功能性RPE细胞的策略,并总结了这些衍生RPE的移植研究。我们总结了使用人类胚胎和诱导多能干细胞衍生的RPE进行细胞置换治疗的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号